Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 233

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease

Open access
Jeong, Sangyun · 2017 · Molecules and Cells

Abstract

The most common form of senile dementia is Alzheimer's disease (AD), which is characterized by the extracellular deposition of amyloid β-peptide (Aβ) plaques and the intracellular formation of neurofibrillary tangles (NFTs) in the cerebral cortex. Tau abnormalities are commonly observed in many neurodegenerative diseases including AD, Parkinson's disease, and Pick's disease. Interestingly, tau-mediated formation of NFTs in AD brains shows better correlation with cognitive impairment than Aβ plaque accumulation; pathological tau alone is sufficient to elicit frontotemporal dementia, but it does not cause AD. A growing amount of evidence suggests that soluble Aβ oligomers in concert with hyperphosphorylated tau (pTau) serve as the major pathogenic drivers of neurodegeneration in AD. Increased Aβ oligomers trigger neuronal dysfunction and network alternations in learning and memory circuitry prior to clinical onset of AD, leading to cognitive decline. Furthermore, accumulated damage to mitochondria in the course of aging, which is the best-known nongenetic risk factor for AD, may collaborate with soluble Aβ and pTau to induce synapse loss and cognitive impairment in AD. In this review, I summarize and discuss the current knowledge of the molecular and cellular biology of AD and also the mechanisms that underlie Aβ-mediated neurodegeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14348/molcells.2017.0096

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 41 references

Research works printed but not linked: 58

  1. Bai, 2015, An atomic structure of human γ-secretase, Nature, 525, 212, 10.1038/nature14892 · DOI · Paper page
  2. Brown, 2000, Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans, Cell, 100, 391, 10.1016/S0092-8674(00)80675-3 · DOI · Paper page
  3. Cai, 2001, BACE1 is the major β-secretase for generation of Aβ peptides by neurons, Nat Neurosci, 4, 233, 10.1038/85064 · DOI · Paper page
  4. Chasseigneaux, 2012, Functions of Aβ, sAPPα and sAPPβ : similarities and differences, J Neurochem, 120, 99, 10.1111/j.1471-4159.2011.07584.x · DOI · Paper page
  5. Chen, 2000, Impairment of hippocampal long-term potentiation by Alzheimer amyloid β-peptides, J Neurosci Res, 60, 65, 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q · DOI · Paper page
  6. Chen, 2006, TMP21 is a presenilin complex component that modulates γ-secretase but not ε-secretase activity, Nature, 440, 1208, 10.1038/nature04667 · DOI · Paper page
  7. Cleary, 2005, Natural oligomers of the amyloid-β protein specifically disrupt cognitive function, Nat Neurosci, 8, 79, 10.1038/nn1372 · DOI · Paper page
  8. Cullen, 1997, Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments, Neuroreport, 8, 3213, 10.1097/00001756-199710200-00006 · DOI · Paper page
  9. De Strooper, 2007, Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO Rep, 8, 141, 10.1038/sj.embor.7400897 · DOI · Paper page
  10. Dineley, 2002, β-Amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes, J Biol Chem, 277, 25056, 10.1074/jbc.M200066200 · DOI · Paper page
  11. Esler, 2001, A portrait of Alzheimer secretases--new features and familiar faces, Science, 293, 1449, 10.1126/science.1064638 · DOI · Paper page
  12. Figueiredo, 2013, Memantine rescues transient cognitive impairment caused by high-molecular-weight aβ oligomers but not the persistent impairment induced by low-molecular-weight oligomers, J Neurosci, 33, 9626, 10.1523/JNEUROSCI.0482-13.2013 · DOI · Paper page
  13. Furukawa, 1996, Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain, J Neurochem, 67, 1882, 10.1046/j.1471-4159.1996.67051882.x · DOI · Paper page
  14. Ghosal, 2009, Alzheimer’s disease-like pathological features in transgenic mice expressing the APP intracellular domain, Proc Natl Acad Sci USA, 106, 18367, 10.1073/pnas.0907652106 · DOI · Paper page
  15. Giliberto, 2010, Transgenic expression of the amyloid-β precursor protein-intracellular domain does not induce Alzheimer’s Disease-like traits in vivo, PLoS One, 5, e11609, 10.1371/journal.pone.0011609 · DOI
  16. Goedert, 2015, NEURODEGENERATION. Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein, Science, 349, 1255555, 10.1126/science.1255555 · DOI · Paper page
  17. Goedert, 2006, A century of Alzheimer’s disease, Science, 314, 777, 10.1126/science.1132814 · DOI · Paper page
  18. Grimm, 2005, Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin, Nat Cell Biol, 7, 1118, 10.1038/ncb1313 · DOI · Paper page
  19. Hamid, 2007, Amyloid precursor protein intracellular domain modulates cellular calcium homeostasis and ATP content, J Neurochem, 102, 1264, 10.1111/j.1471-4159.2007.04627.x · DOI
  20. He, 2010, Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease, Nature, 467, 95, 10.1038/nature09325 · DOI · Paper page
  21. Herreman, 2000, Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells, Nat Cell Biol, 2, 461, 10.1038/35017105 · DOI · Paper page
  22. Hong, 2017, Development of a reporter system for in vivo monitoring of γ-secretase activity in Drosophila, Mol Cells, 40, 73, 10.14348/molcells.2017.2294 · DOI
  23. Hsieh, 2006, AMPAR removal underlies Ab-induced synaptic depression and dendritic spine loss, Neuron, 52, 831, 10.1016/j.neuron.2006.10.035 · DOI · Paper page
  24. Hung, 1993, Activation of protein kinase C inhibits cellular production of the amyloid β-protein, J Biol Chem, 268, 22959, 10.1016/S0021-9258(19)49409-X · DOI · Paper page
  25. IIhara, 1986, Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer’s disease, J Biochem, 99, 1807, 10.1093/oxfordjournals.jbchem.a135662 · DOI · Paper page
  26. Kandel, 2014, The molecular and systems biology of memory, Cell, 157, 163, 10.1016/j.cell.2014.03.001 · DOI · Paper page
  27. Klein, 1999, Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex, Ann N Y Acad Sci, 893, 314, 10.1111/j.1749-6632.1999.tb07845.x · DOI
  28. Knott, 2008, Mitochondrial fragmentation in neurodegeneration, Nat Rev Neurosci, 9, 505, 10.1038/nrn2417 · DOI · Paper page
  29. Kosik, 1986, Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease, Proc Natl Acad Sci USA, 83, 4044, 10.1073/pnas.83.11.4044 · DOI · Paper page
  30. Lambert, 2011, Genetics of Alzheimer’s disease: new evidences for an old hypothesis? Curr, Opin Genet Dev, 21, 295, 10.1016/j.gde.2011.02.002 · DOI
  31. Leissring, 2002, A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP, Proc Natl Acad Sci USA, 99, 4697, 10.1073/pnas.072033799 · DOI · Paper page
  32. Li, 2009, Soluble oligomers of amyloid b protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake, Neuron, 62, 788, 10.1016/j.neuron.2009.05.012 · DOI · Paper page
  33. Lin, 1999, Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation, Proc Natl Acad Sci USA, 96, 12108, 10.1073/pnas.96.21.12108 · DOI
  34. McLean, 1999, Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease, Ann Neurol, 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
  35. Müller, 2008, The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer’s disease, Prog Neurobiol, 85, 393, 10.1016/j.pneurobio.2008.05.002 · DOI · Paper page
  36. Müller-Schiffmann, 2015, Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity, Brain, 139, 509, 10.1093/brain/awv355 · DOI
  37. Nhan, 2016, The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes, Acta Neuropathol, 129, 1, 10.1007/s00401-014-1347-2 · DOI · Paper page
  38. Palop, 2010, Amyloid-β-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks, Nat Neurosci, 13, 812, 10.1038/nn.2583 · DOI · Paper page
  39. Palop, 2016, Network abnormalities and interneuron dysfunction in Alzheimer disease, Nat Rev Neurosci, 17, 777, 10.1038/nrn.2016.141 · DOI · Paper page
  40. Reddy, 2008, Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease, Trends Mol Med, 14, 45, 10.1016/j.molmed.2007.12.002 · DOI · Paper page
  41. Reddy, 2011, Mitochondria as a therapeutic target for aging and neurodegenerative diseases, Curr Alzheimer Res, 8, 393, 10.2174/156720511795745401 · DOI · Paper page
  42. Reinhard, 2005, The amyloid-β precursor protein: integrating structure with biological function, EMBO J, 24, 3996, 10.1038/sj.emboj.7600860 · DOI · Paper page
  43. Ryan, 2005, Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain, J Cell Biol, 171, 327, 10.1083/jcb.200505078 · DOI · Paper page
  44. Selkoe, 1998, The cell biology of β-amyloid precursor protein and presenilin in Alzheimer’s disease, Trends Cell Biol, 8, 447, 10.1016/S0962-8924(98)01363-4 · DOI · Paper page
  45. Simić, 1997, Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer’s disease, J Comp Neurol, 379, 482, 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z · DOI · Paper page
  46. Skovronsky, 2000, Protein kinase C-dependent α-secretase competes withβ-secretase for cleavage of amyloid-β precursor protein in the trans-Golgi network, J Biol Chem, 275, 2568, 10.1074/jbc.275.4.2568 · DOI · Paper page
  47. Small, 2015, Retromer in Alzheimer disease, Parkinson disease and other neurological disorders, Nat Rev Neurosci, 16, 126, 10.1038/nrn3896 · DOI · Paper page
  48. Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci USA, 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
  49. Struhl, 1998, Nuclear access and action of notch in vivo, Cell, 93, 649, 10.1016/S0092-8674(00)81193-9 · DOI · Paper page
  50. Talantova, 2013, Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss, Proc Natl Acad Sci USA, 110, E2518, 10.1073/pnas.1306832110 · DOI · Paper page
  51. Terry, 1991, Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment, Ann Neurol, 30, 572, 10.1002/ana.410300410 · DOI · Paper page
  52. Tu, 2014, Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease, Mol Neurodegener, 9, 48, 10.1186/1750-1326-9-48 · DOI · Paper page
  53. Wang, 2014, FoxO mediates APP-induced AICD-dependent cell death, Cell Death Dis, 5, e1233, 10.1038/cddis.2014.196 · DOI
  54. Wei, 2010, Amyloid beta from axons and dendrites reduces local spine number and plasticity, Nat Neurosci, 13, 190, 10.1038/nn.2476 · DOI · Paper page
  55. Wirths, 2010, Neuron loss in transgenic mouse models of Alzheimer’s disease, Int J Alzheimers Dis, 2010
  56. Zhang, 2000, Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch–1, Nat Cell Biol, 2, 463, 10.1038/35017108 · DOI · Paper page
  57. Zhou, 2005, CD147 is a regulatory subunit of the γ-secretase complex in Alzheimer’s disease amyloid β-peptide production, Proc Natl Acad Sci USA, 102, 7499, 10.1073/pnas.0502768102 · DOI · Paper page
  58. Zhu, 2013, Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer’s disease, Alzheimers Dementia, 9, 733, 10.1016/j.jalz.2012.09.015 · DOI

Cited by

Metadata

Authors
Jeong, S.
Venue
Molecules and Cells
Publisher
Elsevier BV
Published
2017-09
Volume
40
Issue
9
Pages
613-620
ISSN
  • 0219-1032 (ISSN-L)
  • 1016-8478
OpenAlex
W2967414557
Cited by
233
References
41
FWCI
13.73
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.